What is the current Tumor Mice Model market size?

The Tumor Mice Model market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Tumor Mice Model market?

Key drivers include rising cancer research and growing demand for personalized medicine, fueling future outlook.

What challenges does the Tumor Mice Model market face?

Challenges include high operational costs, regulatory hurdles, and ethical concerns surrounding animal testing.

Which regions are leading the Tumor Mice Model market?

North America and Europe are regional leaders, driven by strong research initiatives and infrastructure.

Who are the top companies in the Tumor Mice Model market?

Top companies include Charles River, Jackson Laboratory, and Taconic Biosciences, driving innovation and growth.

What future opportunities exist in the Tumor Mice Model market?

Future opportunities include emerging technologies and increasing adoption in pharmaceutical research, shaping market trends.

How will technology impact the Tumor Mice Model market?

Advances in gene editing and imaging technologies will enhance model accuracy and drive market growth, influencing future outlook.

What is the current regulatory landscape for the Tumor Mice Model market?

Regulatory landscape includes strict guidelines for animal welfare, research protocols, and data management, ensuring compliance.

How will the Tumor Mice Model market evolve in the next 5 years?

The market will evolve through increasing adoption of humanized models, driving personalized medicine and precision oncology research.

Tumor Mice Model Industry Trends & Competitive Analysis 2033

Tumor Mice Model by Application (Contract Research Organizations, Pharma and Biopharma Companies, Academic and Research Institutes, Others), by Types (Humanized Immune System Mice Models, Syngeneic Tumor Mice Models, Immunodeficient Mice Models, NOG Mice Models, Spontaneous Tumor Mice Models, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1880 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1880 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Tumor Mice Model Market Size | CAGR 6.6% Forecast 2033

Tumor Mice Model Industry Trends & Competitive Analysis 2033

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1880 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1880 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Tumor Mice Model Market Overview

The Tumor Mice Model market refers to the use of genetically engineered mice to study cancer and develop new treatments. As a crucial tool in oncology research, the Tumor Mice Model market size is estimated to be around $1.4 billion in 2025. The growth outlook for this market is promising, with a market forecast that indicates a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2026-2033. This industry expansion can be attributed to the increasing demand for personalized medicine and the rising incidence of cancer globally. The scope of this market encompasses various types of tumor models, including xenograft, syngeneic, and genetically engineered models, which are used in applications such as oncology research, drug discovery, and preclinical testing.

Loading chart…

The growth of the Tumor Mice Model market is driven by several key forces, including technology shifts such as the development of CRISPR-Cas9 gene editing technology, regulations such as the increasing demand for personalized medicine, and consumer behavior such as the rising awareness of cancer research. The largest region in this market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to be shaped by the increasing adoption of tumor mice models in oncology research and drug discovery, as well as the growing demand for personalized medicine. As the market continues to evolve, it is likely to be driven by the development of new technologies and the increasing demand for effective cancer treatments.

Report Overview

Report Attribute	Details
Market size value in 2025	1.88 billion
Revenue forecast in 2033	3.28 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	The Jackson Laboratory; Taconic Biosciences; Charles River Laboratories; Shanghai Model Organisms Center Inc.; Envigo; Biocytogen; Genoway; Crown Bioscience Inc.; Cyagen; Applied Stem Cells; Ingenious Targeting Laboratory; PolyGene-Transgenic mice model company; Creative Biolabs; TransCure Bioservices; Champions Oncology Inc; Certis Oncology; Signature; Pharmaron; Laboratory Corporation of America Holdings; Gempharmatech; Janvier Labs; Harbour BioMed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Tumor Mice Model market is experiencing significant growth, driven by increasing demand for personalized medicine and targeted therapies. The Tumor Mice Model market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in genetic engineering and gene editing technologies have enabled the development of more accurate and reliable Tumor Mice Models, driving growth in the Tumor Mice Model market.

Increasing investments in cancer research and the rising prevalence of cancer are fuelling the demand for Tumor Mice Models, contributing to the growth forecast of the Tumor Mice Model market size.

Restraints2 items

High costs associated with the development and maintenance of Tumor Mice Models, as well as concerns regarding animal welfare, are restraining the growth of the Tumor Mice Model market.

Stringent regulatory requirements and the need for specialized expertise in handling Tumor Mice Models are additional factors limiting the expansion of the Tumor Mice Model market size.

Opportunities2 items

The increasing adoption of personalized medicine and targeted therapies is creating new opportunities for the Tumor Mice Model market, with a positive growth forecast.

Emerging economies with growing biotechnology industries are expected to provide new avenues for growth in the Tumor Mice Model market, driving the Tumor Mice Model market size.

Challenges2 items

The complexity of cancer biology and the need for more accurate and reliable Tumor Mice Models pose significant challenges for the Tumor Mice Model market, impacting the growth forecast.

Intense competition among market players and the need for continuous innovation in Tumor Mice Model development are additional challenges facing the Tumor Mice Model market size.

Market Segmentation

Loading chart…

The Tumor Mice Model market can be segmented based on application, which includes oncology research, immunology research, and neurology research. Each application contributes to the overall Tumor Mice Model market size, with oncology research being the largest segment. The Tumor Mice Model segmentation by application provides valuable insights into the market, enabling stakeholders to understand the demand for tumor mice models in different research areas.

The Tumor Mice Model market can also be segmented by type, which includes syngeneic models, xenograft models, and allograft models. Each type has its own set of subtypes, such as [object Object] and [object Object], which are used in various research applications. Understanding the market taxonomy of the Tumor Mice Model market is crucial for industry players to develop effective strategies and make informed decisions. The Tumor Mice Model segmentation by type helps in identifying the most widely used models and their applications, driving the growth of the market.

Tumor Mice Model Segmentation Breakdown12 items

Application

Contract Research Organizations

Pharma and Biopharma Companies

Academic and Research Institutes

Others

Types

Humanized Immune System Mice Models

Syngeneic Tumor Mice Models

Immunodeficient Mice Models

NOG Mice Models

Spontaneous Tumor Mice Models

Others

Regional Insights

Loading chart…

The Tumor Mice Model market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market, driven by factors such as high adoption rates, favorable policies, and significant investments in research and development. The Asia Pacific region, on the other hand, is expected to be the fastest-growing region, driven by increasing demand, expanding infrastructure, and growing ecosystem maturity.

Key drivers for each region include: for North America, established infrastructure and highly developed ecosystem; for Europe, strong regulatory framework and growing demand; for Asia Pacific, rapidly expanding demographics and increasing investments; for Latin America, growing awareness and improving infrastructure; and for Middle East & Africa, rising demand and expanding healthcare sector.

The regional forecast indicates that the Tumor Mice Model market will continue to grow, driven by these key drivers and factors. Understanding the regional dynamics is crucial for market players to develop effective strategies and capitalize on emerging opportunities.

Competitive Landscape

The Tumor Mice Model market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Tumor Mice Model competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies emphasize regional expansion and cost advantages.

Companies in the Tumor Mice Model market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To remain competitive, companies must develop unique value propositions, leveraging technology, service models, channel strength, customization, and cost advantages. The following companies exemplify distinct strategic focuses:

The Jackson Laboratory: regional expansion

Taconic Biosciences: premium pricing

Charles River Laboratories: innovation pipeline

Shanghai Model Organisms Center Inc.: local manufacturing

Envigo: OEM tie-ups

Biocytogen: vertical integration

Key Tumor Mice Model Companies22 items

The Jackson Laboratory

Taconic Biosciences

Charles River Laboratories

Shanghai Model Organisms Center Inc.

Envigo

Biocytogen

Genoway

Crown Bioscience Inc.

Cyagen

Applied Stem Cells

Ingenious Targeting Laboratory

PolyGene-Transgenic mice model company

Creative Biolabs

TransCure Bioservices

Champions Oncology Inc

Certis Oncology

Signature

Pharmaron

Laboratory Corporation of America Holdings

Gempharmatech

Janvier Labs

Harbour BioMed

Market Ecosystem

The Tumor Mice Model ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and technologies are developed; midstream, where these components are integrated into Tumor Mice Models; and downstream, where these models are distributed and utilized by end users. The value in this ecosystem is created through the development and application of Tumor Mice Models in research and drug development, and it is captured by various participants at different stages.

Ecosystem Participants7 items

Raw material suppliers — providing biological materials

Technology providers — developing genetic modification technologies

OEMs/manufacturers — producing Tumor Mice Models

Distributors/channel partners — supplying models to research institutions

Service providers/after-sales — offering model maintenance and support services

End users/buyers — utilizing Tumor Mice Models in research and development

Regulators/standards bodies — setting standards and approving model use

The flow of value through the Tumor Mice Model ecosystem is influenced by several control points, including regulatory approvals and the availability of biological materials. Dependency risks, such as input constraints and standards compliance, can also impact the ecosystem. Furthermore, switching costs and partnerships between participants can affect the adoption of Tumor Mice Models. As part of a thorough value chain analysis, understanding these dynamics is crucial for navigating the Tumor Mice Model ecosystem, which can differ significantly by region due to varying regulatory environments and research priorities.

Recent Industry Insights

The Tumor Mice Model industry has witnessed significant developments over the last 12-18 months, shaping the future of Tumor Mice Model industry trends. Recent partnerships between major pharmaceutical companies and research institutions have accelerated the development of innovative cancer treatments. Notable mergers and acquisitions have also taken place, leading to the expansion of product portfolios and enhancement of research capabilities.

Furthermore, several companies have launched new products and technologies, including advanced in vivo imaging systems and genetically engineered mouse models. Regulatory changes have also been implemented to support the development and approval of cancer therapies. Additionally, there has been a shift in consumer and enterprise trends, with a growing focus on personalized medicine and targeted therapies. Funding rounds and expansions have also been announced, providing further support for research and development in the Tumor Mice Model industry.

Analyst Overview

As the Lead Analyst for this study, I provide a comprehensive overview of the Tumor Mice Model market outlook. The market exhibits high attractiveness due to increasing demand for cancer research and the development of personalized medicine. The competitive intensity is moderate, with key players investing heavily in research and development. The long-term outlook is positive, driven by advancements in genetic engineering and the growing need for effective cancer treatments.

The innovation landscape is dynamic, with ongoing research focused on improving the accuracy and efficiency of tumor mice models. The demand-supply balance is favorable, with suppliers expanding their capacities to meet the growing demand. However, key risk factors include regulatory challenges and ethical concerns surrounding animal testing. Overall, the Tumor Mice Model market is poised for sustained growth, driven by its critical role in cancer research and drug development.

12 items

1. Executive Summary

2. Tumor Mice Model Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Tumor Mice Model Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Tumor Mice Model Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Tumor Mice Model Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Tumor Mice Model Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Tumor Mice Model Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Tumor Mice Model Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Tumor Mice Model Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Tumor Mice Model Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Tumor Mice Model Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Tumor Mice Model Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Tumor Mice Model Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Tumor Mice Model Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Tumor Mice Model Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Tumor Mice Model Market Competition by Key Manufacturers

9.1. Global Tumor Mice Model Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Tumor Mice Model: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. The Jackson Laboratory

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Taconic Biosciences

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Charles River Laboratories

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Shanghai Model Organisms Center Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Envigo

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Biocytogen

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Genoway

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Crown Bioscience Inc.

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Cyagen

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Applied Stem Cells

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Ingenious Targeting Laboratory

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. PolyGene-Transgenic mice model company

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Creative Biolabs

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. TransCure Bioservices

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Champions Oncology Inc

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Certis Oncology

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Signature

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Pharmaron

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Laboratory Corporation of America Holdings

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Gempharmatech

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Janvier Labs

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Harbour BioMed

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Tumor Mice Model Market

Figure 4: Global Tumor Mice Model Market: Drivers

Figure 5: Global Tumor Mice Model Market: Challenges

Figure 6: Global Tumor Mice Model Market: Trends

Figure 7: Global Tumor Mice Model Market: Opportunity

Figure 8: Global Tumor Mice Model Market: Restraint

Figure 9: Global Tumor Mice Model Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Tumor Mice Model Market Value (USD Million) By Region

Figure 19: Global Tumor Mice Model Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Tumor Mice Model Market Value (USD Million) By Region

Figure 27: Global Tumor Mice Model Market Share (%) By: Regions (2032)

Figure 28: Global Tumor Mice Model Market Volume (K) By Region

Figure 29: Global Tumor Mice Model Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Tumor Mice Model Market Value (USD Million) By Region

Figure 37: Global Tumor Mice Model Market Share (%) By: Regions (2032)

Figure 38: Global Tumor Mice Model Market Volume (K) By Region

Figure 39: Global Tumor Mice Model Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

139 items

Table 1: Market Segmentation Analysis

Table 2: Global Tumor Mice Model Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Tumor Mice Model Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Tumor Mice Model Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Tumor Mice Model Market Value (USD Million) By Region

Table 14: Global Tumor Mice Model Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Tumor Mice Model Market Volume (K) By Region

Table 31: Global Tumor Mice Model Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Tumor Mice Model Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Tumor Mice Model Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Tumor Mice Model Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: The Jackson Laboratory Basic Information And Sales Area

Table 52: The Jackson Laboratory. Products Portfolio

Table 53: Taconic Biosciences Basic Information And Sales Area

Table 54: Taconic Biosciences. Products Portfolio

Table 55: Charles River Laboratories Basic Information And Sales Area

Table 56: Charles River Laboratories. Products Portfolio

Table 57: Shanghai Model Organisms Center Inc. Basic Information And Sales Area

Table 58: Shanghai Model Organisms Center Inc.. Products Portfolio

Table 59: Envigo Basic Information And Sales Area

Table 60: Envigo. Products Portfolio

Table 61: Biocytogen Basic Information And Sales Area

Table 62: Biocytogen. Products Portfolio

Table 63: Genoway Basic Information And Sales Area

Table 64: Genoway. Products Portfolio

Table 65: Crown Bioscience Inc. Basic Information And Sales Area

Table 66: Crown Bioscience Inc.. Products Portfolio

Table 67: Cyagen Basic Information And Sales Area

Table 68: Cyagen. Products Portfolio

Table 69: Applied Stem Cells Basic Information And Sales Area

Table 70: Applied Stem Cells. Products Portfolio

Table 71: Ingenious Targeting Laboratory Basic Information And Sales Area

Table 72: Ingenious Targeting Laboratory. Products Portfolio

Table 73: PolyGene-Transgenic mice model company Basic Information And Sales Area

Table 74: PolyGene-Transgenic mice model company. Products Portfolio

Table 75: Creative Biolabs Basic Information And Sales Area

Table 76: Creative Biolabs. Products Portfolio

Table 77: TransCure Bioservices Basic Information And Sales Area

Table 78: TransCure Bioservices. Products Portfolio

Table 79: Champions Oncology Inc Basic Information And Sales Area

Table 80: Champions Oncology Inc. Products Portfolio

Table 81: Certis Oncology Basic Information And Sales Area

Table 82: Certis Oncology. Products Portfolio

Table 83: Signature Basic Information And Sales Area

Table 84: Signature. Products Portfolio

Table 85: Pharmaron Basic Information And Sales Area

Table 86: Pharmaron. Products Portfolio

Table 87: Laboratory Corporation of America Holdings Basic Information And Sales Area

Table 88: Laboratory Corporation of America Holdings. Products Portfolio

Table 89: Gempharmatech Basic Information And Sales Area

Table 90: Gempharmatech. Products Portfolio

Table 91: Janvier Labs Basic Information And Sales Area

Table 92: Janvier Labs. Products Portfolio

Table 93: Harbour BioMed Basic Information And Sales Area

Table 94: Harbour BioMed. Products Portfolio

Table 95: Global Market Value (USD Million) (2025-2032) By Application

Table 96: Global Market Share (%) By Application (2032)

Table 97: Global Market Value (USD Million) (2025-2032) By Types

Table 98: Global Market Share (%) By Types (2032)

Table 99: Global Market Volume (K) (2025-2032) By Application

Table 100: Global Market Share (%) By Application (2032)

Table 101: Global Market Volume (K) (2025-2032) By Types

Table 102: Global Market Share (%) By Types (2032)

Table 103: Global Tumor Mice Model Market Value (USD Million) By Region

Table 104: Global Tumor Mice Model Market Share (%) By Region (2025-2032)

Table 105: North America Market Value (USD Million) (2025-2032) By Country

Table 106: North America Market Value (USD Million) (2025-2032) By Application

Table 107: North America Market Value (USD Million) (2025-2032) By Types

Table 108: Europe Market Value (USD Million) (2025-2032) By Country

Table 109: Europe Market Value (USD Million) (2025-2032) By Application

Table 110: Europe Market Value (USD Million) (2025-2032) By Types

Table 111: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 112: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 113: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 114: South America Market Value (USD Million) (2025-2032) By Country

Table 115: South America Market Value (USD Million) (2025-2032) By Application

Table 116: South America Market Value (USD Million) (2025-2032) By Types

Table 117: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 118: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 119: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 120: Global Tumor Mice Model Market Volume (K) By Region

Table 121: Global Tumor Mice Model Market Share (%) By Region (2025-2032)

Table 122: North America Market Volume (K) (2025-2032) By Country

Table 123: North America Market Volume (K) (2025-2032) By Application

Table 124: North America Market Volume (K) (2025-2032) By Types

Table 125: Europe Market Volume (K) (2025-2032) By Country

Table 126: Europe Market Volume (K) (2025-2032) By Application

Table 127: Europe Market Volume (K) (2025-2032) By Types

Table 128: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 129: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 130: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 131: South America Market Volume (K) (2025-2032) By Country

Table 132: South America Market Volume (K) (2025-2032) By Application

Table 133: South America Market Volume (K) (2025-2032) By Types

Table 134: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 135: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 136: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 137: Research Programs/Design For This Report

Table 138: Key Data Information From Secondary Sources

Table 139: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Tumor Mice Model Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.88 billion
Revenue forecast in 2033	3.28 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	The Jackson Laboratory; Taconic Biosciences; Charles River Laboratories; Shanghai Model Organisms Center Inc.; Envigo; Biocytogen; Genoway; Crown Bioscience Inc.; Cyagen; Applied Stem Cells; Ingenious Targeting Laboratory; PolyGene-Transgenic mice model company; Creative Biolabs; TransCure Bioservices; Champions Oncology Inc; Certis Oncology; Signature; Pharmaron; Laboratory Corporation of America Holdings; Gempharmatech; Janvier Labs; Harbour BioMed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options